Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Diffuse intrinsic pontine glioma
Diffuse midline glioma, H3 K27-altered
A diffuse midline glioma characterized by H3 K27 alteration and usually either a histone H3 K27M mutation, an EGFR mutation, or aberrant overexpression of EZHIP. The prognosis is poor.
-
Diffuse midline glioma, H3 K27M-mutant 31 trials